AI-generated summary
The authors studied low-fluence Q-switched Nd:YAG 1064 nm laser irradiation in melanoma cells, mouse skin and macrophages to explore how it may treat melasma. They report reduced melanin production via DHX9 upregulation and TRIB3 repression, plus lower inflammatory factors and higher phagocytic activity in macrophages. The findings come from cell and animal experiments, so clinical relevance is not established.
- Who or what was studied
- B16F10 murine melanoma cells, C57BL/6J mice skin, and RAW264.7 macrophages
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The study relies on cell lines and mouse models, so the findings may not translate to human melasma patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
- Total energy
- 6J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Inflammation, Fluence, Melanin, Photobiomodulation, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.